Irubis receives 2.8 million euros

The start-up wants to simplify the production of pharmaceuticals. This is now convincing investors such as High-Tech Gründerfonds.
The biotech Irubis has raised 2.8 million euros in its seed round. High-Tech Gründerfonds (HTGF), Verve Ventures and Ventura BioMed invested in the round. The EIC Fund, the Initiative for Industrial Innovators and other business angels also participated. With the new funding, the startup plans to expand its team and bring the next product version to market.
Lorenz Sykora-Mirle, Alexander Geißler and Anja Müller founded Irubis in 2017. The start-up aims to automate the process development and production of biopharmaceutical drugs. It hopes to achieve this with the Monipa measurement system it has developed. The system could simplify the measurement of nutrients in cell cultivation and other quality parameters, it said.
"Sensitive and robust measurements without additional time-consuming calibration are a long-sought need for biopharmaceutical drug production," said Laura Pedroza, investment manager at High-Tech Gründerfonds. "Irubis meets this need with its innovative and reliable Monipa technology."

Newsletter
Startups, stories and stats from the German startup ecosystem straight to your inbox. Subscribe with 2 clicks. Noice.
LinkedIn ConnectTake care, give care
Did this news inform or entertain you? Then we would be happy if you tell your network about it.
Share on Linkedin Share on Facebook Share on XingRelated companies
FYI: English edition available
Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?
FYI: Deutsche Edition verfügbar
Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?